Gene Biotherapeutics, Inc. Operating Leases, Future Minimum Payments Due, Next Twelve Months
Gene Biotherapeutics, Inc. had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $42.79 thousand as of 2016-12-31, per its 10-K filed 2017-07-28.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2017-07-28
- 2016-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $42.79K.
- 2015-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $93.44K.
- 2014-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $121.60K.
- 2013-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $150.46K.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2016-12-31 | $42.79K 10-K · filed 2017-07-28 |
| 2015-12-31 | $93.44K 10-K · filed 2016-12-29 |
| 2014-12-31 | $121.60K 10-K · filed 2015-05-22 |
| 2013-12-31 | $150.46K 10-K · filed 2014-04-15 |
| 2012-12-31 | $443.01K 10-K · filed 2013-04-05 |